Pfizer Com (PFE) Shareholder Sterling Capital Management Has Lowered Its Stake; As United Technologies (UTX) Market Valuation Rose, Holder Torch Wealth Management Has Raised Its Stake

February 22, 2018 - By Vivian Park

Sterling Capital Management Llc decreased its stake in Pfizer Inc Com (PFE) by 2.77% based on its latest 2017Q3 regulatory filing with the SEC. Sterling Capital Management Llc sold 58,632 shares as the company’s stock declined 3.45% while stock markets rallied. The institutional investor held 2.06 million shares of the health care company at the end of 2017Q3, valued at $73.37 million, down from 2.11M at the end of the previous reported quarter. Sterling Capital Management Llc who had been investing in Pfizer Inc Com for a number of months, seems to be less bullish one the $213.16 billion market cap company. The stock decreased 0.69% or $0.25 during the last trading session, reaching $35.76. About 24.55 million shares traded or 13.72% up from the average. Pfizer Inc. (NYSE:PFE) has declined 2.76% since February 22, 2017 and is downtrending. It has underperformed by 19.46% the S&P500.

Torch Wealth Management Llc increased its stake in United Technologies Corp (UTX) by 354.95% based on its latest 2017Q3 regulatory filing with the SEC. Torch Wealth Management Llc bought 10,890 shares as the company’s stock rose 8.03% with the market. The institutional investor held 13,958 shares of the aerospace company at the end of 2017Q3, valued at $1.62M, up from 3,068 at the end of the previous reported quarter. Torch Wealth Management Llc who had been investing in United Technologies Corp for a number of months, seems to be bullish on the $103.38 billion market cap company. The stock increased 2.21% or $2.8 during the last trading session, reaching $129.26. About 7.77M shares traded or 78.00% up from the average. United Technologies Corporation (NYSE:UTX) has risen 22.99% since February 22, 2017 and is uptrending. It has outperformed by 6.29% the S&P500.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1. They expect $0.70 earnings per share, up 1.45% or $0.01 from last year’s $0.69 per share. PFE’s profit will be $4.17 billion for 12.77 P/E if the $0.70 EPS becomes a reality. After $0.62 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 12.90% EPS growth.

Investors sentiment increased to 0.96 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It increased, as 53 investors sold PFE shares while 700 reduced holdings. 106 funds opened positions while 620 raised stakes. 4.06 billion shares or 0.86% more from 4.02 billion shares in 2017Q2 were reported. Rhumbline Advisers reported 9.48M shares or 0.74% of all its holdings. Horrell invested 0% of its portfolio in Pfizer Inc. (NYSE:PFE). Levin Cap Strategies LP invested 6.23% in Pfizer Inc. (NYSE:PFE). Notis accumulated 15,500 shares. Fcg Advsr Ltd Liability Corporation accumulated 9,108 shares or 0.12% of the stock. Brandywine Global Inv Mgmt Limited Liability Co has invested 1.52% of its portfolio in Pfizer Inc. (NYSE:PFE). Moreover, Parsons Capital Ri has 0.98% invested in Pfizer Inc. (NYSE:PFE) for 233,782 shares. Dubuque Fincl Bank Trust has 43,160 shares. Cohen & Steers reported 695,083 shares. Btc Mngmt, a Iowa-based fund reported 119,687 shares. Covington Inv Advisors reported 72,068 shares stake. Welch Gru Ltd Liability Company owns 7,572 shares or 0.05% of their US portfolio. Granite Inv Prns Lc holds 19,865 shares or 0.04% of its portfolio. Trust Co Of Vermont, a Vermont-based fund reported 254,993 shares. Staley Cap Advisers Inc owns 1.02M shares for 2.98% of their portfolio.

Sterling Capital Management Llc, which manages about $45.64 billion and $10.63B US Long portfolio, upped its stake in Gilead Sciences Inc Com (NASDAQ:GILD) by 56,020 shares to 1.22M shares, valued at $98.83 million in 2017Q3, according to the filing. It also increased its holding in Bayer A G Sponsored Adr (BAYRY) by 15,273 shares in the quarter, for a total of 19,536 shares, and has risen its stake in Aflac Inc Com (NYSE:AFL).

Among 22 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 11 Hold. Therefore 45% are positive. Pfizer had 74 analyst reports since July 29, 2015 according to SRatingsIntel. Citigroup downgraded Pfizer Inc. (NYSE:PFE) on Tuesday, May 16 to “Sell” rating. The firm has “Neutral” rating given on Friday, December 2 by Guggenheim. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Tuesday, June 14. Jefferies has “Buy” rating and $42 target. The stock of Pfizer Inc. (NYSE:PFE) earned “Hold” rating by SunTrust on Monday, October 16. BMO Capital Markets maintained the stock with “Hold” rating in Friday, April 28 report. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Thursday, August 4. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Wednesday, August 2. Piper Jaffray has “Buy” rating and $5200 target. The firm has “Hold” rating given on Thursday, October 26 by Jefferies. Jefferies maintained Pfizer Inc. (NYSE:PFE) on Wednesday, August 16 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Wednesday, October 28 by Deutsche Bank.

Since August 31, 2017, it had 0 insider buys, and 7 sales for $12.30 million activity. The insider MACKENZIE ALEXANDER R sold 6,750 shares worth $249,750. Another trade for 38,230 shares valued at $1.34M was made by SUSMAN SALLY on Tuesday, September 12. JOHNSON RADY A had sold 8,000 shares worth $296,560. DAMELIO FRANK A sold $3.21M worth of Pfizer Inc. (NYSE:PFE) on Thursday, August 31.

Among 21 analysts covering United Technologies Corporation (NYSE:UTX), 12 have Buy rating, 0 Sell and 9 Hold. Therefore 57% are positive. United Technologies Corporation had 80 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Monday, January 8. As per Tuesday, October 6, the company rating was upgraded by Numis Securities. Jefferies maintained United Technologies Corporation (NYSE:UTX) rating on Monday, August 28. Jefferies has “Buy” rating and $139.0 target. The firm earned “Hold” rating on Wednesday, October 25 by Stifel Nicolaus. The firm has “Neutral” rating by CItigroup given on Monday, October 10. The stock of United Technologies Corporation (NYSE:UTX) has “Hold” rating given on Friday, July 7 by Stifel Nicolaus. The stock has “Buy” rating by Citigroup on Thursday, September 10. On Tuesday, October 13 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. The rating was downgraded by Deutsche Bank to “Hold” on Wednesday, July 22. The rating was maintained by Bernstein on Tuesday, January 30 with “Hold”.

Investors sentiment increased to 1.05 in 2017 Q3. Its up 0.10, from 0.95 in 2017Q2. It improved, as 63 investors sold UTX shares while 503 reduced holdings. 111 funds opened positions while 484 raised stakes. 621.08 million shares or 1.52% more from 611.76 million shares in 2017Q2 were reported. Whitnell And Co accumulated 16,617 shares. Caxton Associate LP stated it has 35,200 shares. Bowen Hanes Com Inc holds 0.04% in United Technologies Corporation (NYSE:UTX) or 8,110 shares. Donaldson Management Limited Liability Co reported 0.39% in United Technologies Corporation (NYSE:UTX). Univest Of Pennsylvania invested in 27,148 shares. Seabridge Advsr Ltd Liability Corporation holds 0.04% or 1,338 shares in its portfolio. Capital Advisers Llc holds 0.26% in United Technologies Corporation (NYSE:UTX) or 263,638 shares. 6,932 were accumulated by Schnieders Cap Ltd Liability Company. Livforsakringsbolaget Skandia Omsesidigt invested in 0.69% or 65,924 shares. Parametric Assoc Limited Com has 2.22 million shares for 0.29% of their portfolio. Addenda Capital holds 11,000 shares or 0.08% of its portfolio. Orleans Capital Management Corporation La owns 23,642 shares. 45,700 are owned by M. First Bankshares holds 39,733 shares. Kentucky-based Renaissance Group Llc has invested 0.03% in United Technologies Corporation (NYSE:UTX).

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>